Geode Capital Management, LLC Intercept Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$9.99 - $18.71 $1.8 Million - $3.37 Million	180,354 Added 29.42%	793,321 $14.7 Million
Q2 2023 Aug 11, 2023	BUY	$9.17 - $19.29 $124,977 - $262,903	13,629 Added 2.27%	612,967 $6.78 Million
Q1 2023 May 15, 2023	BUY	$12.53 - $21.71 $179,730 - $311,408	14,344 Added 2.45%	599,338 $8.05 Million
Q4 2022 Feb 13, 2023	BUY	$11.61 - $16.11 $1.59 Million - $2.21 Million	137,216 Added 30.64%	584,994 $7.24 Million
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $129,071 - $208,248	10,571 Added 2.42%	447,778 $6.25 Million
Q2 2022 Aug 12, 2022	BUY	$11.23 - $19.59 $495,737 - $864,780	44,144 Added 11.23%	437,207 $6.04 Million
Q1 2022 May 13, 2022	SELL	$13.37 - $17.79 $1.2 Million - $1.6 Million	-89,677 Reduced 18.58%	393,063 $6.4 Million
Q4 2021 Feb 11, 2022	SELL	$14.28 - $19.53 $212,714 - $290,918	-14,896 Reduced 2.99%	482,740 $7.86 Million
Q3 2021 Nov 12, 2021	BUY	$12.99 - $20.47 $116,533 - $183,636	8,971 Added 1.84%	497,636 $7.39 Million
Q2 2021 Aug 13, 2021	BUY	$15.46 - $24.5 $403,892 - $640,062	26,125 Added 5.65%	488,665 $9.76 Million
Q1 2021 May 12, 2021	BUY	$19.33 - $37.75 $1.11 Million - $2.17 Million	57,413 Added 14.17%	462,540 $10.7 Million
Q4 2020 Feb 12, 2021	BUY	$24.48 - $42.47 $76,181 - $132,166	3,112 Added 0.77%	405,127 $10 Million
Q3 2020 Nov 13, 2020	BUY	$39.09 - $53.44 $217,066 - $296,752	5,553 Added 1.4%	402,015 $16.7 Million
Q2 2020 Aug 13, 2020	BUY	$46.7 - $92.04 $653,473 - $1.29 Million	13,993 Added 3.66%	396,462 $19 Million
Q1 2020 May 14, 2020	BUY	$48.35 - $118.68 $1.12 Million - $2.75 Million	23,187 Added 6.45%	382,469 $24.1 Million
Q4 2019 Feb 13, 2020	BUY	$57.36 - $124.1 $1.54 Million - $3.33 Million	26,868 Added 8.08%	359,282 $44.5 Million
Q3 2019 Nov 12, 2019	BUY	$58.69 - $80.46 $219,735 - $301,242	3,744 Added 1.14%	332,414 $22.1 Million
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $3.97 Million - $6.16 Million	51,012 Added 18.37%	328,670 $26.2 Million
Q1 2019 May 14, 2019	BUY	$91.83 - $120.68 $1.63 Million - $2.14 Million	17,772 Added 6.84%	277,658 $31.1 Million
Q4 2018 Feb 13, 2019	BUY	$85.79 - $126.46 $1.89 Million - $2.79 Million	22,059 Added 9.28%	259,886 $26.2 Million
Q3 2018 Nov 13, 2018	BUY	$88.49 - $127.55 $1.63 Million - $2.36 Million	18,467 Added 8.42%	237,827 $30.1 Million
Q2 2018 Aug 14, 2018	BUY	$60.0 - $85.67 $3.24 Million - $4.63 Million	54,044 Added 32.69%	219,360 $18.4 Million
Q1 2018 May 15, 2018	BUY	$52.72 - $67.25 $297,868 - $379,962	5,650 Added 3.54%	165,316 $10.2 Million
Q4 2017 Feb 13, 2018	SELL	$58.2 - $72.76 $112,849 - $141,081	-1,939 Reduced 1.2%	159,666 $9.33 Million
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $550,944 - $1.15 Million	9,664 Added 6.36%	161,605 $9.38 Million
Q2 2017 Aug 14, 2017	BUY	N/A	151,941	151,941 $18.4 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account